Dr. Minjin Jeong | Biology | Best Researcher Award

Dr. Minjin Jeong | Biology | Best Researcher Award

Instructor, Stanford University, United States

๐ŸŽ“ Dr. Minjin Jeong is an accomplished researcher and educator at Stanford University, specializing in auditory science and inner ear disorders. Her pioneering work includes developing human pluripotent stem cell-derived otic organoids and elucidating the mechanisms behind COVID-19-induced hearing loss. With experience spanning South Korea, Europe, and the U.S., Dr. Jeong bridges international collaboration in auditory science research, contributing transformative advancements in her field. ๐ŸŒ๐Ÿ”ฌ

Publication Profile

Google Scholar

Education

๐Ÿ“˜ Dr. Jeong’s academic journey began with a B.S. in Molecular and Life Science (2010, Hanyang University, Korea), followed by an M.S. in Biochemistry (2012, Hanyang University) and a Ph.D. in Genetic Medicine (2017, Newcastle University, UK). Her global education underscores her commitment to advancing auditory research. ๐ŸŒฑ๐Ÿ“š

Experience

๐Ÿ’ก Dr. Jeong’s career spans prestigious roles, including postdoctoral fellowships at Harvard and Stanford University, where she investigated inner ear biology and auditory disorders. She has also served as a research associate at Newcastle University and an instructor at Stanford, contributing to cutting-edge advancements in stem cell and auditory research. ๐Ÿ›๏ธ๐Ÿงฌ

Research Interests

๐Ÿง  Dr. Jeongโ€™s research focuses on human inner ear biology using pluripotent stem cells, addressing the global challenge of hearing loss. Her work aims to develop innovative treatments for inner ear disorders, with a special emphasis on COVID-19-induced audiovestibular dysfunction and congenital hearing loss. ๐Ÿ‘‚๐ŸŒŸ

Awards

๐Ÿ… Dr. Jeong has received numerous honors, including the Newcastle University Overseas Research Scholarship and Hanyang University’s Science and Technology Scholarship. She graduated summa cum laude and has been recognized for her impactful contributions to auditory science. ๐ŸŒŸ๐ŸŽ–๏ธ

Publications

Jeong M., Kurihara S., Stankovic KM. (2024). An In Vitro Oxidative Stress Model of the Human Inner Ear Using Human-Induced Pluripotent Stem Cell-Derived Otic Progenitor Cells. Antioxidants. Read more

Harding AT., Ocwieja K., Jeong M., et al. (2024). Human otic progenitor cell models of congenital hearing loss reveal potential pathophysiologic mechanisms of Zika virus and cytomegalovirus infections. mBio. Read more

Jeong M., et al. (2021). Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction. Commun Med (Lond). Read more

Stojkovic M., Han D., Jeong M., et al. (2021). Human induced pluripotent stem cells and CRISPR/Cas-mediated targeted genome editing: Platforms to tackle sensorineural hearing loss. Stem Cells. Read more

Jeong M., et al. (2018). Generating inner ear organoids containing putative cochlear hair cells from human pluripotent stem cells. Cell Death Dis. Read more

Dr. Ankita Srivastava | Neuroscience | Best Researcher Award

Dr. Ankita Srivastava | Neuroscience | Best Researcher Award

Dr. Ankita Srivastava, NYU Grossman Long Island School of Medicine, United States

Dr. Ankita Srivastava is a Research Associate in the Department of Foundations of Medicine at NYU Grossman Long Island School of Medicine. With a strong foundation in life sciences and applied microbiology, she specializes in molecular biology, focusing on the progression of adipocyte insulin resistance and metabolic disorders. Over her career, she has contributed to critical studies in neurodegeneration and cardiovascular diseases, driven by a passion for understanding complex biological mechanisms.

Profile

Googlescholar

Dr. Ankita Srivastava’s profile demonstrates strong qualifications for the “Best Researcher Award.” Here is an evaluation based on “Strengths for the Award, Areas for Improvement, and Conclusion”:

Strengths for the Award

Dr. Srivastava holds an impressive educational background with a Ph.D. in Biological Science and postdoctoral experience at prestigious institutions like NYU Grossman Long Island School of Medicine.

She has made significant contributions to understanding metabolic disorders, insulin resistance, and neurodegenerative diseases like Alzheimer’s, evidenced by numerous high-impact publications (PMID: 38004296).

Her collaborative efforts in both molecular biology and clinical research, along with various awards like the CSIR Junior and Senior Research Fellowships, showcase her excellence in research.

Areas for Improvement

While Dr. Srivastavaโ€™s research is broad, focusing more on independent leadership roles or securing large grants may enhance her candidacy. A stronger emphasis on presenting her work internationally could increase her global recognition.

Education ๐ŸŽ“

B.Sc. in Life Sciences, M.J.P. Rohilkhand University, U.P., India (07/2008)

M.Sc. in Applied Microbiology and Biotechnology, Banasthali University, India (07/2010)

Ph.D. in Biological Science, CSIR-CDRI, Lucknow, India (09/2017)

Experience ๐Ÿ’ผ

Dr. Srivastava has over a decade of research experience, starting as a CSIR Junior Research Fellow and advancing to her current role at NYU Grossman. She has been involved in groundbreaking research on insulin resistance, obesity, and Alzheimer’s disease, applying her molecular and cell biology expertise to these critical areas.

Research Interests ๐Ÿ”ฌ

Dr. Srivastava’s primary research interests include the molecular mechanisms underlying insulin resistance, obesity, Alzheimer’s disease, and cardiovascular disease. Her focus is on exploring adipose tissue-derived exosomal miRNAs’ role in neurodegeneration and metabolic disorders.

Awards ๐Ÿ†

CSIR Senior Research Fellowship (2014)

CSIR Junior Research Fellowship (2012)

Qualified CSIR NET-JRF (2011) with All India Rank 59

Topped GATE-2012 (Life Science) with 99.99 percentile (All India Rank 1)

Publication Top Notesย ๐Ÿ“š

Srivastava A, et al. “Therapeutic Potential of P110 Peptide: New Insights into Treatment of Alzheimer’s Disease.” Life (Basel). 2023. PMID: 38004296

Peltier MR, et al. “Cholesterol Deficiency as a Mechanism for Autism.” J Investig Med. 2024. PMID: 37864505

Reiss AB, et al. “Mitochondria in Alzheimer’s Disease Pathogenesis.” Life (Basel). 2024. PMID: 38398707

Stecker MM, et al. “Amyloid-ฮฒ Effects on Peripheral Nerve: A New Model System.” Int J Mol Sci. 2023. PMID: 37833938

Godbole S, et al. “Treating Cardiovascular Disease in Rheumatoid Arthritis.” Biomedicines. 2024. PMID: 39062180

 

Conclusion

Dr. Srivastava is highly suitable for the award due to her vast research achievements, multidisciplinary collaborations, and dedication to exploring complex biological mechanisms. Minor improvements in leadership visibility would further strengthen her profile.